Andrus J, Santos J, Evans Gilbert T, Siqueira M, Gentile A, Boshell J
Rev Panam Salud Publica. 2024; 48:e93.
PMID: 39687260
PMC: 11648175.
DOI: 10.26633/RPSP.2024.93.
Mahazabin M, Tabassum N, Syfullah S, Majumder U, Islam M
Prev Med Rep. 2024; 45:102839.
PMID: 39188972
PMC: 11345404.
DOI: 10.1016/j.pmedr.2024.102839.
Rosenfeld K, Frey K, McCarthy K
Vaccines (Basel). 2024; 12(7).
PMID: 39066459
PMC: 11281443.
DOI: 10.3390/vaccines12070820.
Patel C, Sargent G, Tinessia A, Mayfield H, Chateau D, Ali A
PLOS Glob Public Health. 2024; 4(7):e0003068.
PMID: 39052626
PMC: 11271932.
DOI: 10.1371/journal.pgph.0003068.
Durrheim D, Andrus J, Tabassum S, Githanga D, Kojouharova M, Talab N
Vaccines (Basel). 2024; 12(6).
PMID: 38932428
PMC: 11209210.
DOI: 10.3390/vaccines12060699.
The Case for Assessing the Drivers of Measles Vaccine Uptake.
Kaufman J, Rak A, Vasiliadis S, Brar N, Atif E, White J
Vaccines (Basel). 2024; 12(6).
PMID: 38932421
PMC: 11209301.
DOI: 10.3390/vaccines12060692.
Assessment of using Google Trends for real-time monitoring of infectious disease outbreaks: a measles case study.
Wang D, Lang J, Chen Y
Sci Rep. 2024; 14(1):9470.
PMID: 38658657
PMC: 11043416.
DOI: 10.1038/s41598-024-60120-8.
Pacific Island Countries demonstrate the sustained success of a coordinated measles mass vaccination campaign.
Durrheim D, Tuibeqa I, Aho G, Grangeon J, Ogaoga D, Wattiaux A
Lancet Reg Health West Pac. 2024; 42:100998.
PMID: 38274391
PMC: 10808929.
DOI: 10.1016/j.lanwpc.2023.100998.
A phase II/III randomised, comparative study evaluating the safety and immunogenicity of Biological E's live, attenuated Measles-Rubella vaccine in 9-12 month old healthy infants.
Thuluva S, Gunneri S, Turaga K, Reddy Mogulla R, Yerroju V, Peta K
Contemp Clin Trials Commun. 2023; 36:101232.
PMID: 38058513
PMC: 10696430.
DOI: 10.1016/j.conctc.2023.101232.
Suppression of viral RNA polymerase activity is necessary for persistent infection during the transformation of measles virus into SSPE virus.
Sakamoto K, Konami M, Kameda S, Satoh Y, Wakimoto H, Kitagawa Y
PLoS Pathog. 2023; 19(7):e1011528.
PMID: 37494386
PMC: 10406308.
DOI: 10.1371/journal.ppat.1011528.
Challenges Addressing Inequalities in Measles Vaccine Coverage in Zambia through a Measles-Rubella Supplementary Immunization Activity during the COVID-19 Pandemic.
Yang Y, Kostandova N, Mwansa F, Nakazwe C, Namukoko H, Sakala C
Vaccines (Basel). 2023; 11(3).
PMID: 36992192
PMC: 10059977.
DOI: 10.3390/vaccines11030608.
Mitigating Vaccine Hesitancy and Building Trust to Prevent Future Measles Outbreaks in England.
Thompson S, Meyer J, Burnett R, Campbell S
Vaccines (Basel). 2023; 11(2).
PMID: 36851166
PMC: 9962700.
DOI: 10.3390/vaccines11020288.
Estimating the future global dose demand for measles-rubella microarray patches.
Ko M, Malvolti S, Cherian T, Mantel C, Biellik R, Jarrahian C
Front Public Health. 2023; 10:1037157.
PMID: 36726626
PMC: 9885039.
DOI: 10.3389/fpubh.2022.1037157.
China has the momentum to eliminate measles.
Durrheim D, Xu A, Baker M, Hsu L, Takashima Y
Lancet Reg Health West Pac. 2023; 30:100669.
PMID: 36691602
PMC: 9860474.
DOI: 10.1016/j.lanwpc.2022.100669.
Added value of the measles-rubella supplementary immunization activity in reaching unvaccinated and under-vaccinated children, a cross-sectional study in five Indian districts, 2018-20.
Prosperi C, Thangaraj J, Hasan A, Kumar M, Truelove S, Kumar V
Vaccine. 2022; 41(2):486-495.
PMID: 36481106
PMC: 9831119.
DOI: 10.1016/j.vaccine.2022.11.010.
Impact of the COVID-19 pandemic on timeliness and equity of measles, mumps and rubella vaccinations in North East London: a longitudinal study using electronic health records.
Firman N, Marszalek M, Gutierrez A, Homer K, Williams C, Harper G
BMJ Open. 2022; 12(12):e066288.
PMID: 36456017
PMC: 9723415.
DOI: 10.1136/bmjopen-2022-066288.
Seroprevalence of Measles Antibodies in a Highly MMR-Vaccinated Population.
Quach H, Ovsyannikova I, Grill D, Warner N, Poland G, Kennedy R
Vaccines (Basel). 2022; 10(11).
PMID: 36366367
PMC: 9698789.
DOI: 10.3390/vaccines10111859.
Nebulized fusion inhibitory peptide protects cynomolgus macaques from measles virus infection.
Reynard O, Gonzalez C, Dumont C, Iampietro M, Ferren M, Le Guellec S
Nat Commun. 2022; 13(1):6439.
PMID: 36307480
PMC: 9616412.
DOI: 10.1038/s41467-022-33832-6.
A Comprehensive Investigation of the Current Subacute Sclerosing Panencephalitis (SSPE) Treatment Options to Improve Patient Quality of Life.
Pritha A, Medha T, Garg R
Cureus. 2022; 14(8):e28389.
PMID: 36171840
PMC: 9508860.
DOI: 10.7759/cureus.28389.
Cross-Sectional Study of University Students' Attitudes to 'On Campus' Delivery of COVID-19, MenACWY and MMR Vaccines and Future-Proofing Vaccine Roll-Out Strategies.
Webb A, Gogoi M, Weidman S, Woolf K, Zavala M, Ladhani S
Vaccines (Basel). 2022; 10(8).
PMID: 36016175
PMC: 9415485.
DOI: 10.3390/vaccines10081287.
